Bayer's Near-Term Outlook Dominated by Generic Pressures and Crop Science Uncertainty
Bayer’s consumer health business benefits from a narrow economic moat, largely because of its strong brand power. Consumers continue to pay a premium for Aspirin, Aleve, and other over-the-counter ...
Jim Cramer On Regeneron Pharmaceuticals Inc. (REGN) – “I Want You to Own It”
We recently published a list of What Did Jim Cramer Say About These 19 Stocks Recently? In this article, we are going to take ...
Regeneron Pharmaceuticals Has Lost Its Way, But Can It Find It Again?
Regeneron Pharmaceuticals, Inc. faces Eylea revenue decline but shows growth potential with Dupixent & Libtayo. Click for ...
11 Best Pharma Stocks to Buy According to Hedge Funds
The US pharmaceutical sector is experiencing a distinct trend never seen before with large American pharma companies continually looking for medicines in China.
Ocular rises as Needham issues new Buy on lead candidate
Ocular Therapeutix (NASDAQ:OCUL) traded higher in the morning hours on Tuesday after Needham initiated its coverage with a Buy rating and a $15 per share target, citing the potential of its lead ...